Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2003

01-12-2003 | Review

Roles of B cells in rheumatoid arthritis

Authors: Gregg J Silverman, Dennis A Carson

Published in: Arthritis Research & Therapy | Special Issue 4/2003

Login to get access

Abstract

B lymphocytes play several critical roles in the pathogenesis of rheumatoid arthritis. They are the source of the rheumatoid factors and anticitrullinated protein antibodies, which contribute to immune complex formation and complement activation in the joints. B cells are also very efficient antigen-presenting cells, and can contribute to T cell activation through expression of costimulatory molecules. B cells both respond to and produce the chemokines and cytokines that promote leukocyte infiltration into the joints, formation of ectopic lymphoid structures, angiogenesis, and synovial hyperplasia. The success of B cell depletion therapy in rheumatoid arthritis may depend on disruption of all these diverse functions.
Literature
1.
go back to reference Vaughan JH, Chihara T: Lymphocyte function in rheumatic disorders. Arch Intern Med. 1975, 135: 1324-1328. 10.1001/archinte.135.10.1324.CrossRefPubMed Vaughan JH, Chihara T: Lymphocyte function in rheumatic disorders. Arch Intern Med. 1975, 135: 1324-1328. 10.1001/archinte.135.10.1324.CrossRefPubMed
2.
go back to reference Kaplan RA, Curd JG, Deheer DH, Carson DA, Pangburn MK, Muller-Eberhard HJ, Vaughan JH: Metabolism of C4 and factor B in rheumatoid arthritis. Relation to rheumatoid factor. Arthritis Rheum. 1980, 23: 911-920.CrossRefPubMed Kaplan RA, Curd JG, Deheer DH, Carson DA, Pangburn MK, Muller-Eberhard HJ, Vaughan JH: Metabolism of C4 and factor B in rheumatoid arthritis. Relation to rheumatoid factor. Arthritis Rheum. 1980, 23: 911-920.CrossRefPubMed
3.
go back to reference Ruddy S, Britton MC, Schur PH, Austen KF: Complement components in synovial fluid: activation and fixation in seroposi-tive rheumatoid arthritis. Ann NY Acad Sci. 1969, 168: 161-172.CrossRefPubMed Ruddy S, Britton MC, Schur PH, Austen KF: Complement components in synovial fluid: activation and fixation in seroposi-tive rheumatoid arthritis. Ann NY Acad Sci. 1969, 168: 161-172.CrossRefPubMed
4.
go back to reference Ruddy S, Austen KF: The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids. Arthritis Rheum. 1970, 13: 713-723.CrossRefPubMed Ruddy S, Austen KF: The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids. Arthritis Rheum. 1970, 13: 713-723.CrossRefPubMed
5.
go back to reference Goldstein IM, Weissmann G: Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol. 1974, 113: 1583-1588.PubMed Goldstein IM, Weissmann G: Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J Immunol. 1974, 113: 1583-1588.PubMed
6.
go back to reference Borel JF, Keller HU, Sorkin E: Studies on chemotaxis. XI. Effect on neutrophils of lysosomal and other subcellular fractions from leukocytes. Int Arch Allergy Appl Immunol. 1969, 35: 194-205.CrossRefPubMed Borel JF, Keller HU, Sorkin E: Studies on chemotaxis. XI. Effect on neutrophils of lysosomal and other subcellular fractions from leukocytes. Int Arch Allergy Appl Immunol. 1969, 35: 194-205.CrossRefPubMed
8.
go back to reference Youinou PY, Morrow JW, Lettin AW, Lydyard PM, Roitt IM: Specificity of plasma cells in the rheumatoid synovium. I. Immunoglobulin class of antiglobulin-producing cells. Scand J Immunol. 1984, 20: 307-315.CrossRefPubMed Youinou PY, Morrow JW, Lettin AW, Lydyard PM, Roitt IM: Specificity of plasma cells in the rheumatoid synovium. I. Immunoglobulin class of antiglobulin-producing cells. Scand J Immunol. 1984, 20: 307-315.CrossRefPubMed
9.
go back to reference Fehr K, Velvart M, Rauber M, Knopfel M, Baici A, Salgam P, Boni A: Production of agglutinators and rheumatoid factors in plasma cells of rheumatoid and nonrheumatoid synovial tissues. Arthritis Rheum. 1981, 24: 510-519.CrossRefPubMed Fehr K, Velvart M, Rauber M, Knopfel M, Baici A, Salgam P, Boni A: Production of agglutinators and rheumatoid factors in plasma cells of rheumatoid and nonrheumatoid synovial tissues. Arthritis Rheum. 1981, 24: 510-519.CrossRefPubMed
10.
go back to reference Harris J, Vaughan JH: Transfusion studies in rheumatoid arthritis patients. Arthritis Rheum. 1961, 4: 47-55.CrossRefPubMed Harris J, Vaughan JH: Transfusion studies in rheumatoid arthritis patients. Arthritis Rheum. 1961, 4: 47-55.CrossRefPubMed
11.
go back to reference Sutton BJ, Corper AL, Sohi MK, Jefferis R, Beale D, Taussig MJ: The structure of a human rheumatoid factor bound to IgG Fc. Adv Exp Med Biol. 1998, 435: 41-50.CrossRefPubMed Sutton BJ, Corper AL, Sohi MK, Jefferis R, Beale D, Taussig MJ: The structure of a human rheumatoid factor bound to IgG Fc. Adv Exp Med Biol. 1998, 435: 41-50.CrossRefPubMed
12.
go back to reference Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM: T cell activation in rheumatoid synovium is B cell dependent. J Immunol. 2001, 167: 4710-4718.CrossRefPubMed Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM: T cell activation in rheumatoid synovium is B cell dependent. J Immunol. 2001, 167: 4710-4718.CrossRefPubMed
13.
go back to reference Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D: Organ-specific disease provoked by systemic autoimmunity. Cell. 1996, 87: 811-822. 10.1016/S0092-8674(00)81989-3.CrossRefPubMed Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D: Organ-specific disease provoked by systemic autoimmunity. Cell. 1996, 87: 811-822. 10.1016/S0092-8674(00)81989-3.CrossRefPubMed
14.
go back to reference Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, Mathis D, Benoist C: How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol. 2002, 3: 360-365. 10.1038/ni772.CrossRefPubMed Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, Mathis D, Benoist C: How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol. 2002, 3: 360-365. 10.1038/ni772.CrossRefPubMed
15.
go back to reference Maccioni M, Zeder-Lutz G, Huang H, Ebel C, Gerber P, Hergueux J, Marchal P, Duchatelle V, Degott C, van Regenmortel M, Benoist C, Mathis D: Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med. 2002, 195: 1071-1077. 10.1084/jem.20011941.PubMedCentralCrossRefPubMed Maccioni M, Zeder-Lutz G, Huang H, Ebel C, Gerber P, Hergueux J, Marchal P, Duchatelle V, Degott C, van Regenmortel M, Benoist C, Mathis D: Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med. 2002, 195: 1071-1077. 10.1084/jem.20011941.PubMedCentralCrossRefPubMed
16.
go back to reference Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D: Arthritis critically dependent on innate immune system players. Immunity. 2002, 16: 157-168. 10.1016/S1074-7613(02)00275-3.CrossRefPubMed Ji H, Ohmura K, Mahmood U, Lee DM, Hofhuis FM, Boackle SA, Takahashi K, Holers VM, Walport M, Gerard C, Ezekowitz A, Carroll MC, Brenner M, Weissleder R, Verbeek JS, Duchatelle V, Degott C, Benoist C, Mathis D: Arthritis critically dependent on innate immune system players. Immunity. 2002, 16: 157-168. 10.1016/S1074-7613(02)00275-3.CrossRefPubMed
17.
go back to reference Solomon S, Kolb C, Mohanty S, Jeisy-Walder E, Preyer R, Schollhorn V, Illges H: Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35). Eur J Immunol. 2002, 32: 644-651. 10.1002/1521-4141(200203)32:3<644::AID-IMMU644>3.0.CO;2-5.CrossRefPubMed Solomon S, Kolb C, Mohanty S, Jeisy-Walder E, Preyer R, Schollhorn V, Illges H: Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35). Eur J Immunol. 2002, 32: 644-651. 10.1002/1521-4141(200203)32:3<644::AID-IMMU644>3.0.CO;2-5.CrossRefPubMed
18.
go back to reference Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV: Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med. 1996, 184: 2385-2392. 10.1084/jem.184.6.2385.PubMedCentralCrossRefPubMed Sylvestre D, Clynes R, Ma M, Warren H, Carroll MC, Ravetch JV: Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice. J Exp Med. 1996, 184: 2385-2392. 10.1084/jem.184.6.2385.PubMedCentralCrossRefPubMed
19.
go back to reference Abrahams VM, Cambridge G, Lydyard PM, Edwards JC: Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 608-616. 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G.CrossRefPubMed Abrahams VM, Cambridge G, Lydyard PM, Edwards JC: Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 608-616. 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G.CrossRefPubMed
20.
go back to reference Edwards JC, Cambridge G, Abrahams VM: Do self-perpetuating B lymphocytes drive human autoimmune disease?. Immunology. 1999, 97: 188-196. 10.1046/j.1365-2567.1999.00772.x.PubMedCentralCrossRefPubMed Edwards JC, Cambridge G, Abrahams VM: Do self-perpetuating B lymphocytes drive human autoimmune disease?. Immunology. 1999, 97: 188-196. 10.1046/j.1365-2567.1999.00772.x.PubMedCentralCrossRefPubMed
21.
go back to reference Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE: C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest. 2002, 110: 1823-1830. 10.1172/JCI200216577.PubMedCentralCrossRefPubMed Shushakova N, Skokowa J, Schulman J, Baumann U, Zwirner J, Schmidt RE, Gessner JE: C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease. J Clin Invest. 2002, 110: 1823-1830. 10.1172/JCI200216577.PubMedCentralCrossRefPubMed
22.
go back to reference Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM: Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum. 1984, 27: 845-851.CrossRefPubMed Crisp AJ, Chapman CM, Kirkham SE, Schiller AL, Krane SM: Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum. 1984, 27: 845-851.CrossRefPubMed
23.
go back to reference Sylvestre DL, Ravetch JV: A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity. 1996, 5: 387-390. 10.1016/S1074-7613(00)80264-2.CrossRefPubMed Sylvestre DL, Ravetch JV: A dominant role for mast cell Fc receptors in the Arthus reaction. Immunity. 1996, 5: 387-390. 10.1016/S1074-7613(00)80264-2.CrossRefPubMed
24.
go back to reference Tetlow LC, Woolley DE: Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis. 1995, 54: 896-903.PubMedCentralCrossRefPubMed Tetlow LC, Woolley DE: Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis. 1995, 54: 896-903.PubMedCentralCrossRefPubMed
25.
go back to reference Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002, 297: 1689-1692. 10.1126/science.1073176.CrossRefPubMed Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner MB: Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 2002, 297: 1689-1692. 10.1126/science.1073176.CrossRefPubMed
26.
go back to reference Schaller M, Burton DR, Ditzel HJ: Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol. 2001, 2: 746-753. 10.1038/90696.CrossRefPubMed Schaller M, Burton DR, Ditzel HJ: Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat Immunol. 2001, 2: 746-753. 10.1038/90696.CrossRefPubMed
27.
go back to reference Kassahn D, Kolb C, Solomon S, Bochtler P, Illges H: Few human autoimmune sera detect GPI. Nat Immunol. 2002, 3: 411-412. 10.1038/ni0502-411b. author reply 412–413CrossRefPubMed Kassahn D, Kolb C, Solomon S, Bochtler P, Illges H: Few human autoimmune sera detect GPI. Nat Immunol. 2002, 3: 411-412. 10.1038/ni0502-411b. author reply 412–413CrossRefPubMed
28.
go back to reference Schubert D, Schmidt M, Zaiss D, Jungblut PR, Kamradt T: Autoantibodies to GPI and creatine kinase in RA. Nat Immunol. 2002, 3: 411-10.1038/ni0502-411a. author reply 412–413CrossRefPubMed Schubert D, Schmidt M, Zaiss D, Jungblut PR, Kamradt T: Autoantibodies to GPI and creatine kinase in RA. Nat Immunol. 2002, 3: 411-10.1038/ni0502-411a. author reply 412–413CrossRefPubMed
29.
go back to reference Herve CA, Wait R, Venables PJ: Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology. 2003, 42: 986-988. 10.1093/rheumatology/keg271.CrossRefPubMed Herve CA, Wait R, Venables PJ: Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis. Rheumatology. 2003, 42: 986-988. 10.1093/rheumatology/keg271.CrossRefPubMed
30.
go back to reference Matsumoto I, Lee DM, Goldbach-Mansky R, Sumida T, Hitchon CA, Schur PH, Anderson RJ, Coblyn JS, Weinblatt ME, Brenner M, Duclos B, Pasquali JL, El-Gabalawy H, Mathis D, Benoist C: Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum. 2003, 48: 944-954. 10.1002/art.10898.CrossRefPubMed Matsumoto I, Lee DM, Goldbach-Mansky R, Sumida T, Hitchon CA, Schur PH, Anderson RJ, Coblyn JS, Weinblatt ME, Brenner M, Duclos B, Pasquali JL, El-Gabalawy H, Mathis D, Benoist C: Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum. 2003, 48: 944-954. 10.1002/art.10898.CrossRefPubMed
31.
go back to reference Rowley M, Tait B, Mackay IR, Cunningham T, Phillips B: Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum. 1986, 29: 174-184.CrossRefPubMed Rowley M, Tait B, Mackay IR, Cunningham T, Phillips B: Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA-DR4. Arthritis Rheum. 1986, 29: 174-184.CrossRefPubMed
32.
go back to reference Verheijden GF, Rijnders AW, Bos E, Coenende Roo CJ, van Staveren CJ, Miltenburg AM, Meijerink JH, Elewaut D, de Keyser F, Veys E, Boots AM: Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum. 1997, 40: 1115-1125.CrossRefPubMed Verheijden GF, Rijnders AW, Bos E, Coenende Roo CJ, van Staveren CJ, Miltenburg AM, Meijerink JH, Elewaut D, de Keyser F, Veys E, Boots AM: Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum. 1997, 40: 1115-1125.CrossRefPubMed
33.
go back to reference Li NL, Zhang DQ, Zhou KY, Cartman A, Leroux JY, Poole AR, Zhang YP: Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients. Cell Res. 2000, 10: 39-49.CrossRefPubMed Li NL, Zhang DQ, Zhou KY, Cartman A, Leroux JY, Poole AR, Zhang YP: Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients. Cell Res. 2000, 10: 39-49.CrossRefPubMed
34.
go back to reference Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Menard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR, El-Gabalawy HS: Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2000, 2: 236-243. 10.1186/ar93.PubMedCentralCrossRefPubMed Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Menard HA, Zhou ZJ, Palosuo T, Van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HR, El-Gabalawy HS: Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res. 2000, 2: 236-243. 10.1186/ar93.PubMedCentralCrossRefPubMed
35.
go back to reference Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43: 155-163. 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3.CrossRefPubMed Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000, 43: 155-163. 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3.CrossRefPubMed
36.
go back to reference van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ: Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002, 4: 87-93. 10.1186/ar395.PubMedCentralCrossRefPubMed van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ: Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res. 2002, 4: 87-93. 10.1186/ar395.PubMedCentralCrossRefPubMed
37.
go back to reference Asaga H, Ishigami A: Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration. Neurosci Lett. 2001, 299: 5-8. 10.1016/S0304-3940(00)01735-3.CrossRefPubMed Asaga H, Ishigami A: Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration. Neurosci Lett. 2001, 299: 5-8. 10.1016/S0304-3940(00)01735-3.CrossRefPubMed
38.
go back to reference Wahle M, Pierer M, Krause A, Kolker S, Baerwald CG: Decreased catecholamine-induced cell death in B lymphocytes from patients with rheumatoid arthritis. Ann NY Acad Sci. 2002, 966: 425-428.CrossRefPubMed Wahle M, Pierer M, Krause A, Kolker S, Baerwald CG: Decreased catecholamine-induced cell death in B lymphocytes from patients with rheumatoid arthritis. Ann NY Acad Sci. 2002, 966: 425-428.CrossRefPubMed
39.
go back to reference Shimaoka Y, Attrep JF, Hirano T, Ishihara K, Suzuki R, Toyosaki T, Ochi T, Lipsky PE: Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J Clin Invest. 1998, 102: 606-618.PubMedCentralCrossRefPubMed Shimaoka Y, Attrep JF, Hirano T, Ishihara K, Suzuki R, Toyosaki T, Ochi T, Lipsky PE: Nurse-like cells from bone marrow and synovium of patients with rheumatoid arthritis promote survival and enhance function of human B cells. J Clin Invest. 1998, 102: 606-618.PubMedCentralCrossRefPubMed
40.
go back to reference Lopez-Hoyos M, Marquina R, Tamayo E, Gonzalez-Rojas J, Izui S, Merino R, Merino J: Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice. Arthritis Rheum. 2003, 48: 2353-2361. 10.1002/art.11107.CrossRefPubMed Lopez-Hoyos M, Marquina R, Tamayo E, Gonzalez-Rojas J, Izui S, Merino R, Merino J: Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice. Arthritis Rheum. 2003, 48: 2353-2361. 10.1002/art.11107.CrossRefPubMed
41.
go back to reference Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003, 171: 538-541.CrossRefPubMed Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: The conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol. 2003, 171: 538-541.CrossRefPubMed
42.
go back to reference Wagner UG, Kurtin PJ, Wahner A, Brackertz M, Berry DJ, Goronzy JJ, Weyand CM: The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol. 1998, 161: 6390-6397.PubMed Wagner UG, Kurtin PJ, Wahner A, Brackertz M, Berry DJ, Goronzy JJ, Weyand CM: The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J Immunol. 1998, 161: 6390-6397.PubMed
43.
go back to reference Schroder AE, Greiner A, Seyfert C, Berek C: Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 1996, 93: 221-225. 10.1073/pnas.93.1.221.PubMedCentralCrossRefPubMed Schroder AE, Greiner A, Seyfert C, Berek C: Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 1996, 93: 221-225. 10.1073/pnas.93.1.221.PubMedCentralCrossRefPubMed
44.
go back to reference Krenn V, Schalhorn N, Greiner A, Molitoris R, Konig A, Gohlke F, Muller-Hermelink HK: Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue. Rheumatol Int. 1996, 15: 239-247. 10.1007/BF00290377.CrossRefPubMed Krenn V, Schalhorn N, Greiner A, Molitoris R, Konig A, Gohlke F, Muller-Hermelink HK: Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue. Rheumatol Int. 1996, 15: 239-247. 10.1007/BF00290377.CrossRefPubMed
45.
go back to reference Kim HJ, Krenn V, Steinhauser G, Berek C: Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol. 1999, 162: 3053-3062.PubMed Kim HJ, Krenn V, Steinhauser G, Berek C: Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol. 1999, 162: 3053-3062.PubMed
46.
go back to reference Weyand CM, Goronzy JJ: Ectopic germinal center formation in rheumatoid synovitis. Ann NY Acad Sci. 2003, 987: 140-149.CrossRefPubMed Weyand CM, Goronzy JJ: Ectopic germinal center formation in rheumatoid synovitis. Ann NY Acad Sci. 2003, 987: 140-149.CrossRefPubMed
47.
go back to reference Voswinkel J, Weisgerber K, Pfreundschuh M, Gause A: B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection. Arthritis Res. 2001, 3: 189-195. 10.1186/ar297.PubMedCentralCrossRefPubMed Voswinkel J, Weisgerber K, Pfreundschuh M, Gause A: B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection. Arthritis Res. 2001, 3: 189-195. 10.1186/ar297.PubMedCentralCrossRefPubMed
48.
go back to reference Magalhaes R, Gehrke T, Souto-Carneiro MM, Kriegsmann J, Krenn V: Extensive plasma cell infiltration with crystal IgG inclusions and mutated IgV(H) gene in an osteoarthritis patient with lymphoplasmacellular synovitis. A case report. Pathol Res Pract. 2002, 198: 45-50.CrossRefPubMed Magalhaes R, Gehrke T, Souto-Carneiro MM, Kriegsmann J, Krenn V: Extensive plasma cell infiltration with crystal IgG inclusions and mutated IgV(H) gene in an osteoarthritis patient with lymphoplasmacellular synovitis. A case report. Pathol Res Pract. 2002, 198: 45-50.CrossRefPubMed
49.
go back to reference Shiokawa S, Matsumoto N, Nishimura J: Clonal analysis of B cells in the osteoarthritis synovium. Ann Rheum Dis. 2001, 60: 802-805. 10.1136/ard.60.8.802.PubMedCentralCrossRefPubMed Shiokawa S, Matsumoto N, Nishimura J: Clonal analysis of B cells in the osteoarthritis synovium. Ann Rheum Dis. 2001, 60: 802-805. 10.1136/ard.60.8.802.PubMedCentralCrossRefPubMed
50.
go back to reference Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, Goronzy JJ, Weyand CM: Lymphoid neogenesis in rheumatoid synovitis. J Immunol. 2001, 167: 1072-1080.CrossRefPubMed Takemura S, Braun A, Crowson C, Kurtin PJ, Cofield RH, O'Fallon WM, Goronzy JJ, Weyand CM: Lymphoid neogenesis in rheumatoid synovitis. J Immunol. 2001, 167: 1072-1080.CrossRefPubMed
51.
go back to reference Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, Matloubian M, Cyster JG: Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol. 2002, 169: 424-433.CrossRefPubMed Luther SA, Bidgol A, Hargreaves DC, Schmidt A, Xu Y, Paniyadi J, Matloubian M, Cyster JG: Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J Immunol. 2002, 169: 424-433.CrossRefPubMed
52.
go back to reference Weyand CM, Braun A, Takemura S, Goronzy JJ: Lymphoid microstructures in rheumatoid synovitis. Curr Dir Autoimmun. 2001, 3: 168-187.CrossRefPubMed Weyand CM, Braun A, Takemura S, Goronzy JJ: Lymphoid microstructures in rheumatoid synovitis. Curr Dir Autoimmun. 2001, 3: 168-187.CrossRefPubMed
53.
go back to reference Seki T, Selby J, Haupl T, Winchester R: Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 1998, 41: 1356-1364. 10.1002/1529-0131(199808)41:8<1356::AID-ART4>3.0.CO;2-X.CrossRefPubMed Seki T, Selby J, Haupl T, Winchester R: Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 1998, 41: 1356-1364. 10.1002/1529-0131(199808)41:8<1356::AID-ART4>3.0.CO;2-X.CrossRefPubMed
54.
go back to reference Dechanet J, Merville P, Durand I, Banchereau J, Miossec P: The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest. 1995, 95: 456-463.PubMedCentralCrossRefPubMed Dechanet J, Merville P, Durand I, Banchereau J, Miossec P: The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J Clin Invest. 1995, 95: 456-463.PubMedCentralCrossRefPubMed
55.
go back to reference Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, Radbruch A, Manz RA: Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol. 2002, 169: 1277-1282.CrossRefPubMed Hauser AE, Debes GF, Arce S, Cassese G, Hamann A, Radbruch A, Manz RA: Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J Immunol. 2002, 169: 1277-1282.CrossRefPubMed
56.
go back to reference Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M, Muehlinghaus G, Szyska M, Radbruch A, Manz RA: Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol. 2003, 171: 1684-1690.CrossRefPubMed Cassese G, Arce S, Hauser AE, Lehnert K, Moewes B, Mostarac M, Muehlinghaus G, Szyska M, Radbruch A, Manz RA: Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol. 2003, 171: 1684-1690.CrossRefPubMed
57.
go back to reference Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W: Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003, 48: 982-992. 10.1002/art.10860.CrossRefPubMed Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, Migone TS, Hilbert DM, Stohl W: Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum. 2003, 48: 982-992. 10.1002/art.10860.CrossRefPubMed
58.
go back to reference Meffre E, Davis E, Schiff C, Cunningham-Rundles C, Ivashkiv LB, Staudt LM, Young JW, Nussenzweig MC: Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol. 2000, 1: 207-213. 10.1038/79739.CrossRefPubMed Meffre E, Davis E, Schiff C, Cunningham-Rundles C, Ivashkiv LB, Staudt LM, Young JW, Nussenzweig MC: Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol. 2000, 1: 207-213. 10.1038/79739.CrossRefPubMed
59.
go back to reference Wang YH, Stephan RP, Scheffold A, Kunkel D, Karasuyama H, Radbruch A, Cooper MD: Differential surrogate light chain expression governs B-cell differentiation. Blood. 2002, 99: 2459-2467. 10.1182/blood.V99.7.2459.CrossRefPubMed Wang YH, Stephan RP, Scheffold A, Kunkel D, Karasuyama H, Radbruch A, Cooper MD: Differential surrogate light chain expression governs B-cell differentiation. Blood. 2002, 99: 2459-2467. 10.1182/blood.V99.7.2459.CrossRefPubMed
60.
go back to reference Silverman GJ, Weisman S: Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum. 2003, 48: 1484-1492. 10.1002/art.10947.CrossRefPubMed Silverman GJ, Weisman S: Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy. Arthritis Rheum. 2003, 48: 1484-1492. 10.1002/art.10947.CrossRefPubMed
61.
go back to reference Nishimoto N, Yoshizaki K, Maeda K, Kuritani T, Deguchi H, Sato B, Imai N, Suemura M, Kakehi T, Takagi N, Kishimoto T: Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study. J Rheumatol. 2003, 30: 1426-1435.PubMed Nishimoto N, Yoshizaki K, Maeda K, Kuritani T, Deguchi H, Sato B, Imai N, Suemura M, Kakehi T, Takagi N, Kishimoto T: Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study. J Rheumatol. 2003, 30: 1426-1435.PubMed
Metadata
Title
Roles of B cells in rheumatoid arthritis
Authors
Gregg J Silverman
Dennis A Carson
Publication date
01-12-2003
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 4/2003
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1010

Other articles of this Special Issue 4/2003

Arthritis Research & Therapy 4/2003 Go to the issue